Work

Metformin may reduce Alzheimer’s disease risk by increasing soluble amyloid-β42 levels

Year: 2024

Type: article

Abstract: Timothy Daly, Bruno P Imbimbo; Metformin may reduce Alzheimer’s disease risk by increasing soluble amyloid-β42 levels, Brain, , awae367, https://doi.org/10

Source: Brain

DOI: 10.1093/brain/awae367

Authors: Timothy Daly, Bruno P Imbimbo

Institutions: Centre National de la Recherche Scientifique, Université de Bordeaux, Inserm, Facultad Latinoamericana de Ciencias Sociales Sede Argentina, Bordeaux Population Health, Immunology from Concept and Experiments to Translation, Chiesi (Italy)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Institut National de la Santé et de la Recherche Médicale

OpenAlex ID: W4404191498

FWCI: 2.153

Cites: 10

Cited by: 9

Related to: 10